| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/08/2006 | US20060121480 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/08/2006 | US20060120965 Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives |
| 06/07/2006 | EP1666587A1 Cyclic lipopeptide acylase |
| 06/07/2006 | EP1666486A1 Compound modified with glycerol derivative |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1664269A2 Alpha-keto carbonyl calpain inhibitors |
| 06/07/2006 | EP1664092A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 06/07/2006 | EP1664091A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/07/2006 | EP1664090A2 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus |
| 06/07/2006 | EP1664089A1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664084A1 Process for the manufacture of an enantiopure compound |
| 06/07/2006 | EP1534718A4 Chemical synthesis of reagents for peptide coupling |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1315738A4 Extended native chemical ligation |
| 06/07/2006 | CN1784418A Synthesis of n- [n-(3,3-dimethylbutyl)-l-a-aspartyl] -l-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors |
| 06/07/2006 | CN1784244A Prodrugs cleavable by CD26 |
| 06/07/2006 | CN1784145A Hydrolysed casein product comprising tripeptides ipp and/ or vpp |
| 06/07/2006 | CN1781933A Thymosin alpha 1 active segment cyclicpeptide analogue and its poly glycol derivative |
| 06/07/2006 | CN1781932A Adriamycin derivative and its preparing method and use |
| 06/06/2006 | US7057016 Process for the production of biologically active protein |
| 06/06/2006 | US7056947 For inhibiting (cysteine) proteases/caspases; for treatment of viral infections, stroke, neurodegenerative disease, and inflammatory diseases |
| 06/06/2006 | US7056884 Reduced FK228 and use thereof |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056509 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 06/06/2006 | US20060149081 Easily available starting material e.g starting with 1-(1-cyclohexen-1-yl)-pyrrolidine with benzyl (2S)-2-[(tert -butoxycarbonyl)-amino]-3-iodopropanoate; good yield and purity |
| 06/06/2006 | CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives |
| 06/06/2006 | CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 06/01/2006 | WO2006057303A1 Glycopeptide antibiotic monomer derivatives |
| 06/01/2006 | WO2005041757A3 Detection of neuropeptides associated with pelvic pain disorders and uses thereof |
| 06/01/2006 | US20060116327 Antimicrobial compounds |
| 06/01/2006 | US20060116316 Heterocyclic inhibitors of IRES-mediated translation and methods of use thereof |
| 06/01/2006 | US20060115451 Modified cytokines for use in cancer therapy |
| 06/01/2006 | CA2588285A1 Glycopeptide antibiotic monomer derivatives |
| 06/01/2006 | CA2587775A1 Plasmin-inhibitory therapies |
| 05/31/2006 | EP1661909A1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 05/31/2006 | EP1661566A2 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 05/31/2006 | EP1660663A2 Methods and compositions for tissue repair |
| 05/31/2006 | EP1660521A2 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 05/31/2006 | EP1660517A2 Nogo receptor antagonists |
| 05/31/2006 | EP1660436A1 Cathepsin inhibitors |
| 05/31/2006 | EP1660112A2 Orally administered small peptides synergize statin activity |
| 05/31/2006 | EP1660080A1 Furanone derivatives |
| 05/31/2006 | EP1660017A2 Amino acid prodrugs |
| 05/31/2006 | EP1604032A4 Method for detecting prognosis of cancer |
| 05/31/2006 | EP1272223B1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 05/31/2006 | EP0791076B1 Diagnostic method and kit for determining kell blood group genotype |
| 05/31/2006 | CN1781021A N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 05/31/2006 | CN1780851A Method and carrier complexes for delivering molecules to cells |
| 05/31/2006 | CN1780639A Angiotensin-converting enzyme inhibitory peptides |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/30/2006 | US7053081 Cyclic malonamides as inhibitors of A-β protein production |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053055 Compounds of unstable DP IV-inhibitors |
| 05/26/2006 | WO2006054396A1 Cyclic isodityrosine derivatives |
| 05/26/2006 | WO2006053783A1 Amide and peptide derivatives of tetraalkylenepentamines as transfection agents |
| 05/26/2006 | WO2006053782A1 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents |
| 05/26/2006 | WO2006053700A1 Agonists and antagonists of the somatostatin receptor |
| 05/26/2006 | WO2005115174A3 Alpha-msh-antagonist didpeptide conjugates |
| 05/26/2006 | CA2582384A1 Agonists and antagonists of the somatostatin receptor |
| 05/25/2006 | US20060111553 Novel thrombin inhibitors, the preparation and use thereof |
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/25/2006 | US20060110777 Structured peptide scaffold for displaying turn libraries on phage |
| 05/24/2006 | EP1658036A2 Estrogen receptor modulators and uses thereof |
| 05/24/2006 | EP1383480A4 Lipid-comprising drug delivery complexes and methods for their production |
| 05/24/2006 | EP1337550B1 Hepatitis c tripeptide inhibitors |
| 05/24/2006 | EP1227848B1 Method for linking molecular substances |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/23/2006 | US7049486 Plasmid coding virginiae butanolide; virginiamycin; BAR receptor binding proteins |
| 05/23/2006 | US7049323 Amidoheterocycles as modulators of the melanocortin-4 receptor |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/23/2006 | US7049297 Indazole peptidomimetics as thrombin receptor antagonists |
| 05/23/2006 | US7049296 For therapy and prophylaxis of Alzheimer's disease |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049061 use of R-2,4-diaminobutyric acid as a replacement for gamma-aminobutyric acid to make the hairpin loop; bind to the minor groove of a promoter region of a DNA sequence; tighter binding of the polyamides to the minor groove of DNA and also provides an amine function for derivatizing |
| 05/18/2006 | WO2006052391A2 Heterocyclic inhibitors of ires-mediated translation and methods of use thereof |
| 05/18/2006 | WO2006052201A1 Use of derivatives of dipeptides for the manufacture of a medicament for the treatment of microbial infections |
| 05/18/2006 | WO2006052031A1 Protein hydrolysate with antidiabetic effect |
| 05/18/2006 | WO2006050862A1 Statine derivatives for the treatment of alzheimer's disease |
| 05/18/2006 | WO2006050861A2 Statine derivatives for the treatment of alzheimer's disease |
| 05/18/2006 | WO2005115149A3 Insectidal activity of a cyclic peptide |
| 05/18/2006 | WO2005077044A3 Rational design and engineering of proteins and peptides for immunomodulation |
| 05/18/2006 | WO2004006837A3 Mesothelin vaccines and model systems |
| 05/18/2006 | US20060106199 Streptavidin-binding peptide |
| 05/18/2006 | US20060105960 New selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics |
| 05/18/2006 | US20060104992 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating HIV |
| 05/18/2006 | US20060104907 Biologically potent analogues of the Dmt-Tic pharmacophore and methods of use |
| 05/18/2006 | US20060104899 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/18/2006 | CA2585442A1 Protein hydrolysate with antidiabetic effect |
| 05/17/2006 | EP1656946A1 Tissue adhesive using synthetic crosslinking |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774449A Inhibitors of MEMAPSIN2 and use thereof |
| 05/17/2006 | CN1774446A Identification of N-alkylglycine trimers for induction of apoptosis |
| 05/16/2006 | US7045636 MCH antagonists for the treatment of obesity |
| 05/16/2006 | US7045592 In situ chlorination, to generate amino acid chlorides, utilizing for solid phase peptide synthesis |
| 05/16/2006 | US7045310 Measuring the concentration of preferential analyte in sample; obtain samples, incubate with binding particles, determine concentration of detectable particles |
| 05/11/2006 | WO2006050328A1 Improved quenching methods for red blood cell inactivation process |